Familial hypertriglyceridemia: an entity with distinguishable features from other causes of hypertriglyceridemia.
Ivette Cruz-BautistaAlicia Huerta-ChagoyaHortensia Moreno-MacíasRosario Rodríguez-GuillénMaría Luisa Ordóñez-SánchezYayoi Segura-KatoRoopa MehtaPaloma Almeda-ValdésLizeth Gómez-MunguíaXimena Ruiz-De ChávezXimena Rosas-FlotaArali Andrade-AmadoBárbara Bernal-BarroetaMaría Guadalupe López-CarrascoLuz Elizabeth Guillén-PinedaAngelina López-EstradaDaniel Elías-LópezAlexandro J Martagón-RosadoDonají Gómez-VelascoCesar Ernesto Lam-ChungOmar Yaxmehen Bello-ChavollaFabiola Del Razo-OlveraLucely D Cetina-PérezJosé Luis Acosta-RodríguezMaría Teresa Tusié-LunaCarlos Alberto Aguilar-SalinasPublished in: Lipids in health and disease (2021)
The clinical and genetic differences observed between FHTG and CHTG supports the notion that FHTG is a unique entity, distinguishable from other causes of hypertriglyceridemia by the higher concentrations of insulin, FGF-21, ANGPTL3, apo A-II and lower levels of apo B. We propose the inclusion of these parameters as useful markers for differentiating FHTG from other causes of hypertriglyceridemia.